Roche’s Gazyva/Gazyvaro (obinutuzumab) has demonstrated superiority over standard therapy in patients with active lupus ...

The European Commission (EC) has already approved Valneva’s chikungunya vaccine Ixchiq for use in individuals aged 18 years ...

Inizio has announced that it has appointed Remco op den Kelder as president of Inizio Advisory.

Patient involvement is a concept covering the ways people can share their views and experiences to shape the healthcare ...

Heart failure is a common medical condition, with new treatment approaches being developed every day. By 2030, an estimated 8 ...

Healthcare professionals (HCPs) are increasingly seeking flexibility and convenience in their interactions with ...

Novo Nordisk has shared positive results from a late-stage study of its investigational haemophilia A therapy Mim8 in ...

An international clinical trial aimed at preventing Alzheimer’s disease (AD) in young adults who are at risk of developing ...

Inizio has announced that it has appointed Colin Stanley as its new chief commercial officer. Stanley brings over 30 years of ...

We are the Havas Lynx, a leading healthcare communications agency with a full-service global offering and almost 500 multi-disciplinary specialists in Manchester, London, and New York. We are Havas ...